Eva Y.-H.P. Lee

University of California, Irvine — United States

Medicine · Health Sciences

39h-index12.0kcitations100works12.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(30), Axon Guidance and Neuronal Signaling(30), DNA Repair Mechanisms(15), Ocular Oncology and Treatments(13), Carcinogens and Genotoxicity Assessment(8)

Publications100 total

Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors
British Journal of Cancer·2024· 12 citedOpen Access
Supplementary Figure 1 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 6 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Data from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 1 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 3 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 2 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 5 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 3 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 6 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 4 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 4 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 2 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 5 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 4 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 4 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 1 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 2 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Table 3 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
Supplementary Figure 5 from Activation of Robo1 Signaling of Breast Cancer Cells by Slit2 from Stromal Fibroblast Restrains Tumorigenesis via Blocking PI3K/Akt/β-Catenin Pathway
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Wen‐Hwa Lee(14), Jin‐Yuh Shew(9), Wen‐Hwa Lee(9), Shyng‐Shiou F. Yuan(8), Yung‐Ming Jeng(8), Robert Bookstein(5), King‐Jen Chang(5), Phang‐Lang Chen(4), Wendy W. Hwang‐Verslues(4), Wen‐Hung Kuo(4), Yu‐Wen Tien(4), Ming‐Chu Chang(4), Yu‐Ting Chang(4), Yuewei Qian(3), Po-Hao Chang(3), Chun-Kai Huang(3), Bingnan Gu(3), Stephen X. Skapek(3), Suh-Chin J. Lin(3), Nanpin Hu(2)